Search by Drug Name or NDC
NDC 00121-0677-16 TRICITRATES 334; 550; 500 mg/5mL; mg/5mL; mg/5mL Details
TRICITRATES 334; 550; 500 mg/5mL; mg/5mL; mg/5mL
TRICITRATES is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PAI Holdings, LLC. The primary component is CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE.
Product Information
| NDC | 00121-0677 |
|---|---|
| Product ID | 0121-0677_ef78d6ad-c6b3-4891-8728-910687da39b0 |
| Associated GPIs | 56202030102020 |
| GCN Sequence Number | 048561 |
| GCN Sequence Number Description | sod/pot/K cit/sod cit/cit acid SOLUTION 500-550/5 ORAL |
| HIC3 | R1S |
| HIC3 Description | URINARY PH MODIFIERS |
| GCN | 14027 |
| HICL Sequence Number | 003681 |
| HICL Sequence Number Description | SODIUM/POTASSIUM/POTASSIUM CITRATE/SODIUM CITRATE/CIT AC |
| Brand/Generic | Generic |
| Proprietary Name | TRICITRATES |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 334; 550; 500 |
| Active Ingredient Units | mg/5mL; mg/5mL; mg/5mL |
| Substance Name | CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE |
| Labeler Name | PAI Holdings, LLC |
| Pharmaceutical Class | Acidifying Activity [MoA], Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calcul |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00121-0677-16 (00121067716)
| NDC Package Code | 0121-0677-16 |
|---|---|
| Billing NDC | 00121067716 |
| Package | 473 mL in 1 BOTTLE (0121-0677-16) |
| Marketing Start Date | 2005-05-25 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.02871 |
| Pricing Unit | ML |
| Effective Date | 2023-12-20 |
| NDC Description | TRICITRATES ORAL SOLUTION |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis